CTRI/2020/07/026856尚未招募未知
A randomized, single-dose, double-blind, 4-way, 4â??sequencecrossover, study to assess the bioavailability and pharmacokineticsof CCL formulations in comparisons with unformulated bioactivesin healthy volunteers
Akay Natural Ingredients Pvt Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Subjects who are willing to give their written informed consent and comply with the protocol requirements.
- •2. Females of child bearing age, agree to use approved birth control methods during the study, and have negative urine pregnancy test (UPT) at screening
- •3. Subject understands the study procedures, is ready to comply and provide signed informed consent form (ICF) to participate in the study
排除标准
- •1. Subjects who have consumed food containing any ingredients of the formulation within 2 days prior to screening
- •2. Subjects having symptoms of viral infection, including COVID-19 infection
- •3. Pregnant or lactating women.
- •4. Subjects with known hypersensitivity to the investigational products.
- •5. Subjects who have participated in any clinical trial in the past 1 month.
- •6. Any subjects found to have entered in to the study in violation of this protocol or if the subject is uncooperative during the study.
- •7. Any other condition that in the opinion of the investigator that does not justify the subjectâ??s participation in the study
研究者
相似试验
尚未招募
不适用
A study to evaluate the bioavailability of DF-22 in comparison with unformulated ingredient in healthy volunteersCTRI/2022/11/047672Akay Natural Ingredients Pvt. Ltd
进行中（未招募）
不适用
A randomized, partially-blinded, single-dose, 4-way crossover study to evaluate the efficacy, safety, tolerability and pharmacokinetics of orally inhaled indacaterol maleate administered via the Concept1 device or as a PulmoSphere® formulation via the Simoon deviceMedDRA version: 12.0Level: LLTClassification code 10003553Term: AsthmaAsthmaEUCTR2009-012600-48-GBovartis Pharma AG36
进行中（未招募）
不适用
A randomized, partially-blinded, single-dose, 4-way crossover study to evaluate the efficacy, safety, tolerability and pharmacokinetics of orally inhaled indacaterol maleate administered via the Concept1 device or as a PulmoSphere® formulation via the Simoon deviceAsthmaMedDRA version: 12.0Level: LLTClassification code 10003553Term: AsthmaEUCTR2009-012600-48-DEovartis Pharma Services AG36
进行中（未招募）
不适用
A randomized, partially-blinded, single-dose, 4-way crossover study to evaluate the efficacy, safety, tolerability and pharmacokinetics of orally inhaled indacaterol maleate administered via the Concept1 device or as a PulmoSphere® formulation via the Simoon deviceAsthmaMedDRA version: 12.0Level: LLTClassification code 10003553Term: AsthmaEUCTR2009-012600-48-NLovartis Pharma AG36
进行中（未招募）
1 期
The PALM-study (Placebo, Losartan, Low sodium & Moxonidine after PE)Post Partum Hypertension after preeclamptic pregnancyEUCTR2014-002524-27-NLniversity Medical Center Utrecht